Arbutus Biopharma Corp (ABUS) › Shareholders' EquityArbutus Biopharma Corp (ABUS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $10.79M2011: $5.23M2012: $40.92M2013: $59.19M2014: $88.03M2015: $547.68M2016: $203.00M2017: $182.47M2018: $200.23M2019: $72.74M2020: $101.97M2021: $169.44M2022: $136.85M2023: $106.02M2024: $97.37M2025: $76.58M$76.58M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$76.58M-21.4%2024$97.37M-8.2%2023$106.02M-22.5%2022$136.85M-19.2%2021$169.44M+66.2%2020$101.97M+40.2%2019$72.74M-63.7%2018$200.23M+9.7%2017$182.47M-10.1%2016$203.00M-62.9%2015$547.68M+522.1%2014$88.03M+48.7%2013$59.19M+44.7%2012$40.92M+682.7%2011$5.23M-51.6%2010$10.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share